Tenders for disease control service delivery contracts under the National Pest Management Strategy for Bovine Tuberculosis are closed for 2003.
The Board's mission is the eradication of bovine tuberculosis from New Zealand
RESULTS OF 2003 TENDERING PROCESS
The contracts are in place for the following services:
Tb testing in Taranaki; Manawatu/Wanganui; Nelson/Golden Bay; and Marlborough/Kaikoura
Tb testing in Northland; Wellsford to Harbour Bridge; Harbour Bridge to Drury; Gisborne/Wairoa; North Waikato; South Waikato; Ruapehu; Taupo Basin; Bay of Plenty; Hawke's Bay; Horowhenua/Wellington; and West Coast
Tb Testing of Cattle in North Canterbury, Otago, Clutha/Gore and Southland
Tb Testing of Cattle in South Canterbury
Histopathology to diagnose M. bovis
- Gribbles Veterinary Pathology New Zealand Ltd
Tb Testing of Cattle in Hauraki/Coromandel and Wairarapa
Movement Control/Animal Identification Compliance Monitoring
Disease Control Administration under a single national contract
District Disease Control Management in all but the Taupo Basin
District Disease Control Management in the Taupo Basin
Audit and Assurance Services
The preferred tenderers for the following contract is
Blood Testing to diagnose M. bovis
CALL CENTRE & INFORMATION SERVICES, DATA ENTRY, CASING
As a result of current policy development regarding the management of the National Livestock Database, AHB has postponed tendering of the following services:
- Casing
- Call Centre and Information Services
- Data Entry
It is anticipated that tenders will be called for these services in the 2004 calendar year. In the interim, AHB has negotiated with the current supplier, AgriQuality Ltd, for provision of these services.
LABORATORY SERVICES
- Two of the laboratory services contracts originally posted on this website - REA Typing and Culture - have been amalgamated and withdrawn from the tender process. AHB is negotiating directly with the current supplier, AgResearch Ltd, to provide these services.
- The scope of the contract to be tendered for Blood Testing is to be limited to the use of the "Bovigam" TM gamma interferon test. AHB is not considering contracts for the use of equivalent tests as previously stated.